## **What is the HCPCS code J7327 for?**
The HCPCS code J7327 is one of the many J codes used to designate an injected medication. For this code, what is being injected is hyaluronan (or a derivative of it) or Monovisc, and it is a single intra-articular injection. The HCPCS code counts one dose as one unit.
This injected medicine inserts hyaluronic acid into a joint space. What the medicine does is to alleviate the pain that the patient feels in the joint (almost always the knee pain), and provides a lubricant and shock absorber effect to it as well, which alleviates symptoms of osteoarthritis. This may include patients with specific subtypes such as unilateral secondary osteoarthritis or post-traumatic osteoarthritis, where added lubrication and shock absorption can significantly reduce pain and improve function. It also improves joint mobility and joint function, allowing the patient to have a better quality of life.
This is only meant to be used on patients who have already tried conservative nonpharmacologic therapy (like physical therapy) and other forms of conservative treatment, and they did not respond adequately to those treatments.
## **Documentation requirements for J7327**
As with any procedure, especially involving injecting drugs into patients, it's important to document the following before you file for a claim that includes this code:
- The full name of the personnel who administered the injection and their credentials
- The name and address of the facility where the injection was administered
- The full name of the patient
- The date and time of the drug administration by injection
- Patient records showing they have been diagnosed with a joint disorder or osteoarthritis of the knee joint
- Patient records showing they have tried conservative treatment and they weren't effective
- Documentation of the physical examination of the affected joint
- Clinical documentation showing osteoarthritis of the knee, supported by history and physical examination findings, to clearly establish medical necessity. Imaging such as X-rays or MRI may be included when available, but it is not universally required for coverage.
- The specific dose (Monovisc/hyaluronan), or specific doses for subsequent courses/repeat injections
- If this isn't the patient's first dose of it, there should be documentation of the effectiveness and reduction of symptoms, such as better knee functional capacity or less symptomatic osteoarthritis
## **Billing requirements for J7327**
Besides the documentation requirements above, please note the following billing requirements for this specific code:
- They must reflect the dosage given over the course of the treatment.
- Use either of two modifiers: JW if there's unused medication in a vial (wastage), or JZ if there's no unused medication.
- The appropriate site modifier of RT for the right side, or LT for the left side
Monovisc usually comes in a pre-filled syringe, so you might not need to use JW often. Please make sure you follow CMS/Medicare or similar service mandates to avoid problems with billing and claim rejections.
## **Other similar codes**
- **J7324** - Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
- **J7321** - Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
- **J7326** - Hyaluronan or derivative, gel-one, for intra-articular injection, per dose
- **J7323** - Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose
- **J7322** - Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
- **J7325** - Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
Frequently asked questions
